Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2020-10-28 Remuneration Information
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
2019年限制性股票激励计划实施考核管理办法
Remuneration Information Classification · 95% confidence The document is a detailed management policy regarding the implementation and assessment of a restricted stock incentive plan for company executives and key personnel. It outlines governance structure, performance evaluation criteria, assessment periods, and procedures related to stock incentives. It is not a financial report, earnings release, or regulatory filing but rather a governance and management document focused on compensation and incentive mechanisms. This fits best under Remuneration Information (DEF 14A), which covers reports detailing compensation and incentive plans for executives and directors.
2020-10-28 Chinese
关于召开2020年第二次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2020 second extraordinary general meeting of shareholders for a company, detailing the meeting time, location, voting methods, agenda items, and procedures for attendance and voting. It includes instructions for shareholders on how to participate in the meeting and vote, as well as an authorization proxy form. There is no financial data, earnings information, or report content. The document is an announcement related to a shareholders meeting rather than the meeting materials or results themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2020-10-28 Chinese
独立董事关于第二届董事会第十六次会议有关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the 16th meeting of the second board of directors of a company. It includes assessments related to adjustments in a 2019 restricted stock incentive plan and the appointment of a deputy general manager. The content focuses on governance and compliance with laws and company articles, rather than financial results or audit findings. The document is relatively short (996 characters) and does not contain financial statements or detailed financial data. It is a formal opinion related to board/management decisions and appointments, fitting the category of Board/Management Information (MANG).
2020-10-28 Chinese
第二届监事会第十五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company regarding the approval of the company's 2020 third quarter report and an adjustment to the 2019 restricted stock incentive plan performance indicators. It includes details about the meeting, voting results, and references to where the full third quarter report is published (on an external website and newspapers). The document itself does not contain the full financial statements or substantive financial data of the third quarter report but rather the Supervisory Board's approval and confirmation of the report's compliance and accuracy. The document length is short (1093 characters) and serves as an announcement of the meeting resolutions and approvals, not the report itself. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution disclosure, rather than an Interim/Quarterly Report (IR) or Annual Report (10-K).
2020-10-28 Chinese
北京国枫律师事务所关于公司调整2019年限制性股票激励计划部分业绩考核指标相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding adjustments to a 2019 restricted stock incentive plan of a company. It discusses legal compliance, approvals by the board and shareholders, and adjustments to performance assessment indicators related to the stock incentive plan. It is not a financial report, earnings release, or regulatory filing about financial results. It is a standalone legal opinion related to corporate governance and stock incentive plans, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement or a certification. The document is best classified as a Regulatory Filing (RNS) because it is a legal opinion document related to corporate governance and stock incentive adjustments, which does not fit other more specific categories.
2020-10-28 Chinese
第二届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 16th meeting of the 2nd Board of Directors of the company. It includes details about the meeting date, attendance, voting results on various agenda items such as approval of the 2020 Q3 report, adjustments to stock incentive plans, changes in securities representatives, appointment of a deputy general manager, and scheduling of an extraordinary shareholders meeting. The document does not contain the actual financial report or detailed financial data but rather announces decisions and references where the full reports can be found. It also includes announcements related to board and management changes. Therefore, the document fits best under 'Board/Management Information' (MANG) as it primarily reports on board meeting resolutions and management appointments.
2020-10-28 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.